MS AJINOMOTO BIO PHARMA SERVICES INDIA PRIVATE LIMITED

MS AJINOMOTO BIO PHARMA SERVICES INDIA PRIVATE LIMITED is a Manufacturer.

Company Introduction:

MS Ajinomoto Bio-Pharma Services India Private Limited is the Indian entity of Ajinomoto Bio-Pharma Services, a global Contract Development and Manufacturing Organization (CDMO). As a CDMO, the company specializes in providing a full range of development and manufacturing services for the biopharmaceutical industry.

Their services encompass process development, cGMP (current Good Manufacturing Practice) manufacturing of active pharmaceutical ingredients (APIs), intermediates, and drug products for both clinical and commercial supply. They possess expertise across various therapeutic modalities, including small molecules, oligonucleotides, antibody-drug conjugates (ADCs), and biologics.

The company operates manufacturing facilities and plays a critical role in the pharmaceutical supply chain by offering integrated solutions from early-stage development to commercial production. Leveraging the global footprint and technological capabilities of its parent company, Ajinomoto Co., Inc., MS Ajinomoto Bio-Pharma Services India Private Limited supports pharmaceutical and biotechnology companies in advancing their drug candidates and bringing new therapies to patients worldwide.

MS AJINOMOTO BIO PHARMA SERVICES INDIA PRIVATE LIMITED, as a contract development and manufacturing organization (CDMO), primarily provides services for the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for other pharmaceutical and biopharmaceutical companies. They do not typically sell branded finished pharmaceutical products directly to the market under their own name.

Their core services involve the manufacturing of:

Small Molecule Active Pharmaceutical Ingredients (APIs)

Advanced Intermediates

Additionally, they offer services such as:

Process development and optimization for pharmaceutical compounds

Analytical development and quality control for pharmaceutical substances